SEC Form 4 · accession 0000899243-17-006165
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
William F Doyle
Officer — Executive Chairman · Director · 10% Owner
WFD Ventures Fund II, L.P.
10% Owner · Other
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 7:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF4,F1 | Feb 28, 2017 | M | 686,836 | $3.59 | A | 19,822,874 | I | WFD Ventures Fund II, L.P. |
| Ordinary SharesF1 | Feb 28, 2017 | F | 324,440 | $7.60 | D | 19,498,434 | I | WFD Ventures Fund II, L.P. |
| Ordinary SharesF1 | Feb 28, 2017 | M | 525,618 | $3.59 | A | 20,024,052 | I | WFD Ventures Fund II, L.P. |
| Ordinary SharesF1 | Feb 28, 2017 | F | 248,285 | $7.60 | D | 19,775,767 | I | WFD Ventures Fund II, L.P. |
| Ordinary SharesF5 | holding | — | — | — | 84,699 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF1,F6 | $3.59 | Feb 28, 2017 | M | 686,836 | D | — | Jul 31, 2017 | Ordinary Shares | 686,836 | 0 | I |
| WarrantsF1,F6 | $3.59 | Feb 28, 2017 | M | 525,618 | D | — | Jul 21, 2018 | Ordinary Shares | 525,618 | 0 | I |
| WarrantsF6 | $3.59 | holding | — | — | — | — | Jul 31, 2017 | Ordinary Shares | 6,498 | 6,498 | D |
| WarrantsF6 | $3.59 | holding | — | — | — | — | Jul 21, 2018 | Ordinary Shares | 3,879 | 3,879 | D |
Explanation of responses
- F1Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.
- F2Reflects 324,440 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 362,396 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.
- F3Reflects 248,285 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 277,333 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.
- F4The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by WFD Ventures Fund II, L.P. WFD Ventures Fund II, L.P. beneficially owned 19,136,038 ordinary shares following the transactions reported by the aforementioned Form 4/A.
- F5The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by William F. Doyle. William F. Doyle beneficially owned 84,699 ordinary shares following the transactions reported by the aforementioned Form 4/A.
- F6Currently exercisable as of the date hereof.